Expert Recommendations in Relapsed/Refractory Multiple Myeloma

In this on demand webcast, expert faculty discuss best practices in treating patients
with relapsed/refractory multiple myeloma. 

MYSummit Myeloma Conference - Cancelled

Due to the impact of COVID-19, the MYSummit Conference
has been cancelled

Myeloma News

Keep up to date on the latest multiple myeloma news and information.

Featured Content

Myeloma News

Recent Publications

The Heparanase/Syndecan-1 Axis in Cancer Progression

FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.0I190. ABSTRACT Although oncogenic mutations are considered the primary drivers of tumor initiation, latter steps in cancer progression including angiogenesis, invasion and metastasis are greatly influenced...

Twitter Discussions